Background and Objectives: Breast surgery for cancer is associated with chr
onic pain and sensory abnormalities. The present study investigates the eff
ect of regional block, oral mexiletine, and the combination of both, on acu
te and chronic pain associated with cancer breast surgery.
Methods: One hundred patients scheduled for cancer breast surgery received
either regional block with 18 mt of 1% ropivacaine intraoperatively and ora
l mexiletine for the first 6 postoperative days (R + M group), or regional
block and placebo, (R + FL), or normal saline instead of ropivacaine and me
xiletine (PL + M), or normal saline acid placebo (PL + FL). Postoperative a
nalgesic requirements were recorded daily. Pain was assessed 0, 3, 6, 9, an
d 24 hours in the postanesthesia care unit (PACU) and on the second to sixt
h day postoperatively, at rest. and after movement using the visual analog
scale (VAS). Three months after surgery, patients were interviewed for the
presence and intensity ol pain, abnormal sensations, and analgesic requirem
ents.
Results: Regional block reduced the number of intramuscular (IM) injections
required the first 24 hours (P = .05), the R + PL group requiring less inj
ections versus the PL + M group (P = .037). Lonarid tablet (paracetamol and
codeine) consumption from the second to the fifth postoperative day differ
ed among the 4 groups (P = .0304). the R + M group requiring fewer tablets
than the PL + PL group (P = .009). Three hours postoperatively, the R + PL
group had less pain at rest when compared with all other groups (P < .05 fo
r all comparisons). On the second postoperative day, VAS at rest and alter
movement was less in the R + M versus the R + PL group (P <less than> .01 a
nd P < .05, respectively). Three months after surgery. the 4 groups were si
milar with regard to incidence or intensity of pain or analgesic requiremen
ts. The R + PL group had a lower incidence (77%) of reduced or absent sensa
tion (P = .016).
Conclusions: Regional block reduced the analgesic requirements in the early
postoperative period, while mexiletine combined with regional block reduce
d the total analgesic requirements during the next 5 postoperative days. Al
though chronic pain was not affected by these treatments late-abnormal sens
ation may be diminished by combination of these treatments.